CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ABUS — Arbutus Biopharma Corp
CIK 884546
SAN FRANCISCO, CA
Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,869,846
+$564,640 QoQ
Shares Held
1,431,218
+2.1% QoQ
Ownership
0.723%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 175 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ABUS ranks #122 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ABUS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,869,846 | 1,431,218 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,305,206 | 1,401,157 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,514,494 | 1,562,265 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,787,741 | 1,274,833 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,874,331 | 1,253,829 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,265,006 | 1,222,065 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,996,597 | 1,222,201 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,667,147 | 1,212,246 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,176,001 | 380,583 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $875,174 | 339,215 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $873,395 | 349,358 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $709,196 | 349,358 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $772,967 | 336,073 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $936,176 | 308,969 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $711,302 | 305,280 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $548,970 | 287,419 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $780,355 | 287,954 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $714,344 | 239,713 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $814,468 | 209,375 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $898,218 | 209,375 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $564,998 | 186,468 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $69,636 | 20,912 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $74,237 | 20,912 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $103,014 | 32,912 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||